2019 MEETINGS
48th GENERAL ASSEMBLY OF ERIC MEMBERS AT ASH 2019
8 DECEMBER, 2019 (ORLANDO, USA)
- ERIC Agenda
- Chl+ Obinutuzumab in first line: a study outside clinical trials– Y. Herishanu
- Final analysis of the BTK mutation project – L. Scarfò
- Update on the certification and recertification process – S. Pavlova
4th HARMONY GENERAL ASSEMBLY 2019
26-27 SEPTEMBER, 2019 (FLORENCE, ITALY)
XVIII INTERNATIONAL WORKSHOP ON CLL (iwCLL)
20-23 SEPTEMBER, 2019 (EDINBURGH, SCOTLAND)
WORKSHOP ON BIOMARKERS FOR IMPROVED RISK STRATIFICATION
02 JULY, 2019 (TEL AVIV, ISRAEL)
- AGENDA
- Introduction: ERIC – Paolo Ghia
- Precision medicine in CLL: which are the pre- requisites? – Kostas Stamatopoulos
47th ERIC GENERAL ASSEMBLY OF ERIC MEMBERS AT EHA 2019|
13-16 JUNE, 2019 (AMSTERDAM, NETHERLANDS)
- AGENDA – 47 ERIC General Assembly at EHA 2019
- Welcome and Introduction – Paolo Ghia
- Retreatment after Venetoclax – Antonio Cuneo
- A Retrospective Study to Examine the Efficacy and Safety of Obinutuzumab + Chlorambucil – Yair Herishanu
- ERIC Project on TP53-Mutated Minor Clones Analysis – Sarka Pospisilova
- ERIC Database Launch- Carol Moreno
- AGENDA – ERIC Scientific Workshop
- Chemoimmunotherapy in the RR setting Still useful – B. Eichhorst
- Sequencing therapy for the relapsedrefractory CLL – F. Cymbalista
EDUCATIONAL WORKSHOP ON IMMUNOGLOBULIN GENE ANALYSIS ON CLL
28-29 MARCH, 2019 (BETHESDA, US)
- AGENDA
- Welcome – A. Wiestner, P. Ghia
- On the road to CLL – P. Ghia
- IG genes in CLL biological aspects – K. Stamatopoulos
- Mechanisms of immunoglobulin diversity – F. Davi
- From the patient to the sequence Primers, PCR, Detection of clonality, Sanger sequencing – L. Sutton
- IMGT tools for interpretation of IG gene sequence data – V. Giudicelli
- Specific challenges in IG gene interpretation and tailored bioinformatics solutions – A. Hadzidimitriou
- Practical exercises: Basic – K. Stamatopoulos
- Practical exercises: Advanced – A. Agathangelidis & F. Davi
- Targeting signaling pathways to treat CLL – A. Wiestner
- Prognostic considerations – R. Rosenquist
- NGS IG analysis – basic principles – A. Langerak
- How to report IG gene sequences – L. Sutton
- The ERIC IG Network – A. Hadzidimitriou
- VIDEO: Chronic Lymphocytic Leukemia Treatment: CLL Ig Workshop (Day 1)
- VIDEO: Chronic Lymphocytic Leukemia Treatment: CLL Ig Workshop (Day 2)
ERIC WORKSHOP ON MRD ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA
15-16 MARCH, 2019 (STRESA, ITALY)
- AGENDA
- Introduction – Paolo Ghia
- Treatment landscape of CLL – Peter Hillman
- The role of MRD in CLL – Paolo Ghia
- Laboratory considerations for MRD – Andy Rawstron
- Focus on molecular MRD analysis – Kostas Stamatopoulos
- Focus on cellular MRD analysis – Andy Rawstron
- Focus on imaging + MRD – Peter Hillman
46th GENERAL ASSEMBLY OF ERIC MEMBERS AT ELN 2019
12 FEBRUARY, 2019 (MANNHEIM, GERMANY)
- AGENDA
- Welcome and Introduction – Paolo Ghia
- Use of BR in treatment naïve patient with CLL outside clinical trials – A. Cuneo
- Immunogenetics and stereotypy project – A. Agathangelidis
- Prevalence of BTK and PLCγ2 Mutations in Patients relapsing under Ibrutinib – L. Scarfò
- ERIC study on prognostic and predictive impact of minor TP53 variants – S. Pospisilova
- ERIC TP53 Certification – Results of Round 7 – S. Pavlova
- ERIC IG Certification – Results of Round 4 – A. Agathangelidis